OrthoPediatrics Corp. (KIDS) Reaches $20.33 After 4.00% Up Move; Last Week Nostrum Oil & Gas PLC (LON:NOG) Analysts

April 17, 2018 - By Adrian Mccoy

Nostrum Oil & Gas PLC (LON:NOG) Logo

The stock of OrthoPediatrics Corp. (NASDAQ:KIDS) is a huge mover today! The stock increased 4.18% or $0.815 during the last trading session, reaching $20.325. About 56,588 shares traded or 15.68% up from the average. OrthoPediatrics Corp. (NASDAQ:KIDS) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.The move comes after 5 months positive chart setup for the $259.57 million company. It was reported on Apr, 17 by Barchart.com. We have $21.14 PT which if reached, will make NASDAQ:KIDS worth $10.38M more.

Among 8 analysts covering Nostrum Oil Gas Plc (LON:NOG), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Nostrum Oil Gas Plc had 64 analyst reports since July 28, 2015 according to SRatingsIntel. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, March 28 report. As per Wednesday, December 23, the company rating was upgraded by RBC Capital Markets. The rating was maintained by Peel Hunt with “Buy” on Tuesday, October 31. The stock of Nostrum Oil & Gas PLC (LON:NOG) earned “Hold” rating by Deutsche Bank on Wednesday, January 31. Numis Securities maintained it with “Buy” rating and GBX 560 target in Thursday, October 19 report. On Monday, December 7 the stock rating was maintained by Panmure Gordon with “Buy”. The stock of Nostrum Oil & Gas PLC (LON:NOG) earned “Hold” rating by Deutsche Bank on Tuesday, May 31. The stock of Nostrum Oil & Gas PLC (LON:NOG) has “Buy” rating given on Wednesday, November 18 by Numis Securities. Credit Suisse downgraded Nostrum Oil & Gas PLC (LON:NOG) on Tuesday, November 29 to “Neutral” rating. On Tuesday, July 28 the stock rating was maintained by Numis Securities with “Buy”. See Nostrum Oil & Gas PLC (LON:NOG) latest ratings:

28/03/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 400.00 New Target: GBX 400.00 Maintain
27/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 510.00 New Target: GBX 510.00 Maintain
27/02/2018 Broker: Credit Suisse Rating: Outperform New Target: GBX 400.00 Maintain
19/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 510.00 New Target: GBX 510.00 Maintain
09/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 510.00 New Target: GBX 510.00 Maintain
31/01/2018 Broker: Deutsche Bank Rating: Hold Old Target: GBX 385.00 New Target: GBX 350.00 Maintain
31/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 640.00 New Target: GBX 510.00 Maintain
30/01/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 440.00 New Target: GBX 440.00 Maintain
22/01/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 530.00 New Target: GBX 500.00 Maintain
19/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 640.00 New Target: GBX 640.00 Maintain

OrthoPediatrics Corp. designs, develops, and sells orthopedic implants for children. The company has market cap of $259.57 million. It offers trauma and deformity correction products, including cannulated screws; The Locking Cannulated Blade plate system that offers various treatment options for pediatric hip deformity, fixed knee flexion deformity, and trauma; The Locking Proximal Femur plate system for long bone fractures and osteotomies in children and adolescents; flexible nailing systems; The OP PediFrag System, a fragment set for pediatric orthopedic surgery; The PediLoc Extension Osteotomy plates; locking plated systems for the treatment of pediatric femur fractures and osteotomies; intramedullary nails; plate systems that provide physeal tethering techniques; and an engineered device for casting procedures. It currently has negative earnings. The firm also offers spine and sports medicine systems, and clinical education.

Analysts await OrthoPediatrics Corp. (NASDAQ:KIDS) to report earnings on June, 6. After $-3.93 actual earnings per share reported by OrthoPediatrics Corp. for the previous quarter, Wall Street now forecasts -92.88% EPS growth.

OrthoPediatrics Corp. (NASDAQ:KIDS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.